Page last updated: 2024-08-17

medroxyprogesterone acetate and Benign Neoplasms

medroxyprogesterone acetate has been researched along with Benign Neoplasms in 78 studies

Research

Studies (78)

Timeframe	Studies, this research(%)	All Research%
pre-1990	33 (42.31)	18.7374
1990's	24 (30.77)	18.2507
2000's	13 (16.67)	29.6817
2010's	5 (6.41)	24.3611
2020's	3 (3.85)	2.80

Authors

Authors	Studies
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L	1
Chung, I; Godoy, A; Gunasagran, Y; Mat Adenan, NA; Omar, IS; Teo, IH	1
Crandall, CJ; Manson, JE; Mehta, JM	1
Anderson, GL; Aragaki, AK; Chlebowski, RT; Gass, M; Johnson, KC; Kuller, LH; Manson, JE; Prentice, RL; Rossouw, JE; Shadyab, AH; Stefanick, ML; Wactawski-Wende, J; Wallace, R	1
Bhupathiraju, SN; Grodstein, F; Hu, FB; Manson, JE; Rosner, BA; Stampfer, MJ; Willett, WC	1
Macciò, A; Madeddu, C; Mantovani, G; Panzone, F; Tanca, FM	1
Freeman, S; Shulman, LP	1
Chen, SZ; Zhang, YL	1
Fujita, S; Hata, A; Horai, A; Katakami, N; Kitajima, N; Ose, T; Takatori, K	1
Wren, LM	1
Rosenfield, AG	1
Bonte, J; Ide, P; Wijnants, P	1
Jegou, B; Velez De La Calle, JF	1
Pike, MC; Spicer, DV; Ursin, G	1
Mcdaniel, EB	1
Castegnaro, E; Lenaz, GR; Martoni, A; Pannuti, F; Piana, E; Sala, G	1
London, RS	1
Jones, M	1
Greenspan, A	1
Chandran, R	1
Kaunitz, AM	1
Antonietti, C; Gilli, G; Lelli, G; Montanari, M; Scapoli, D	1
ANDERSON, DG	1
Machens, K; Schmidt-Gollwitzer, K	1
Kuhl, H; Stevenson, J	1
Ben-Yehuda, D; Katz, D; Meirow, D; Or, R; Rabinovici, J; Shufaro, Y	1
Contu, P; Deiana, L; Dessì, M; Floris, C; Gramignano, G; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Panzone, F; Sanna, E; Serpe, R; Tanca, FM	1
Anderson, GL; Aragaki, A; Beresford, SA; Brzyski, R; Chlebowski, RT; Gass, M; Heiss, G; LaCroix, A; Manson, JE; Prentice, RL; Rossouw, J; Stefanick, ML; Wallace, R	1
Bakry, S; Fadiel, A; Mahmoud, MS; Merhi, ZO; Naftolin, F; Scalise, TJ	1
Amato, G; Capuano, F; Carella, C; Figlia, A; Papaleo, C; Zito, GA	1
Pawlicki, M; Zuchowska-Vogelgesang, B	1
Battaglia, A; Bernardo, G; Brunner, K; Cavalli, F; Ganzina, F; Goldhirsch, A; Isetta, AM; Robustelli della Cuna, G; Sacchetti, G; Tamassia, V	1
Camaggi, CM; Canova, N; Giovannini, M; Murari, G; Pannuti, F; Strocchi, E	1
Angelelli, B; Camaggi, CM; Costanti, B; Ferrari, P; Giovannini, M; Pannuti, F; Strocchi, E; Zebini, E	1
Angelelli, B; Camaggi, CM; Colalongo, F; Costanti, B; Giambiasi, ME; Lelli, G; Pannuti, F; Strocchi, E	1
DeStefano, F; Guidotti, R; Jones, V; Layde, PM; Levenson, AG; Michelson, M; Ory, HW; Peterson, H; Rubin, GL; Wingo, P	1
Ordelman, GJ	1
Priestman, TJ	1
Revaz, C	1
Angelelli, B; Lelli, G; Mondini, F; Monetti, N; Pannuti, F; Piana, E; Strocchi, E; Zanichelli, L	1
Oldenkamp, EP; van Laar, PH; van Os, JL; Verschoor, JS	1
Minkin, S	1
Fraser, IS; Weisberg, E	1
Benagiano, G; Fraser, I	1
Allbright, A; Downer, S; Joel, S; Plant, H; Slevin, M; Stubbs, L; Talbot, D	1
Aaronson, NK; Blijham, GH; Cobben, EG; Demedts, M; Drenth, BM; Erdkamp, FL; Hillen, HF; Muller, MJ; Schoon, EJ; Schouten, HC; Simons, JP; Smeets, JB; ten Velde, GP; Vansteenkiste, JF; Wouters, EF	1
Del Giacco, S; Dessì, D; Esu, S; Lai, P; Macciò, A; Mantovani, G; Massa, E; Melis, G; Santona, MC	1
Garosi, VL; Intini, C; Neri, B	1
Del Giacco, GS; Dessì, D; Esu, S; Lai, P; Macciò, A; Mantovani, G; Massa, E; Melis, GB; Santona, MC	1
Hoefnagels, JM; Schols, AM; Simons, JP; ten Velde, GP; Westerterp, KR; Wouters, EF	1
Ghiani, M; Lai, P; Macciò, A; Mantovani, G; Massa, E; Santona, MC	2
Akbulut, H; Aydin, F; Demirkazik, A; Içli, F; Samur, M	1
Toi, M	1
Ogawa, M; Yamashita, JI	1
Mantovani, G	1
Leary, WE	1
Barrett-Connor, E; Cauley, J; Furberg, C; Grady, D; Haskell, W; Hulley, S; Hunninghake, D; Knopp, R; Lowery, M; Satterfield, S; Schrott, H; Vittinghoff, E	1
Anderson, RA; Irvine, DS; Kelnar, CJ; Sharpe, RM; Thomson, AB; Wallace, WH	1
Geyer, G; Lang, I; Spona, J; Templ, H; Zielinski, CC	1
Keller, PJ	1
Camaggi, CM; Pannuti, F; Strocchi, E	1
Beghelli, P; Camaggi, CM; Costanti, B; Ferrari, P; Pannuti, F; Strocchi, E	1

Reviews

17 review(s) available for medroxyprogesterone acetate and Benign Neoplasms

Article	Year
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nature cell biology, 2015, Volume: 17, Issue:11 Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction	2015
Management of Menopausal Symptoms: A Review. JAMA, 2023, 02-07, Volume: 329, Issue:5 Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism	2023
Medroxyprogesterone acetate in the management of cancer cachexia. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:8 Topics: Animals; Cachexia; Humans; Medroxyprogesterone Acetate; Neoplasms	2009
Considerations for the use of progestin-only contraceptives. Journal of the American Academy of Nurse Practitioners, 2010, Volume: 22, Issue:2 Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States	2010
Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal. Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:3 Topics: Anorexia; Cachexia; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Metoclopramide; Neoplasms; Prognosis; Risk Assessment; Severity of Illness Index; Survival Analysis; Terminally Ill; Treatment Outcome; Wasting Syndrome	2003
Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma? Human reproduction (Oxford, England), 2003, Volume: 18, Issue:10 Topics: Biometry; Cardiovascular Diseases; Coronary Disease; Data Collection; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Hip Fractures; Humans; Medroxyprogesterone Acetate; Neoplasms; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Risk	2003
Depot-medroxyprogesterone acetate: an update. Archives of gynecology and obstetrics, 2008, Volume: 278, Issue:1 Topics: Abnormalities, Drug-Induced; Anemia, Sickle Cell; Animals; Arachnoiditis; Body Weight; Bone Density; Contraceptive Agents, Female; Female; Humans; Hypertension; Lactation; Lipoproteins; Liver; Medroxyprogesterone Acetate; Neoplasms	2008
[New antineoplastic agents, their value and use]. Przeglad lekarski, 1982, Volume: 39, Issue:8 Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids	1982
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. The Medical journal of Australia, 1981, 01-24, Volume: 1, Issue:SP1 Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms	1981
The Depo-Provera debate. Commentary on the article "Depo-Provera, a critical analysis". Contraception, 1981, Volume: 24, Issue:5 Topics: Animals; Breast Feeding; Carbohydrate Metabolism; Carcinogens; Delayed-Action Preparations; Dogs; Endometrium; Family Planning Services; Female; Haplorhini; Humans; Immunosuppression Therapy; Infant, Newborn; Liver; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; Risk; United States; United States Food and Drug Administration	1981
Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting. Bulletin of the World Health Organization, 1993, Volume: 71, Issue:6 Topics: Animals; Delayed-Action Preparations; Drug Approval; Epidemiologic Methods; Humans; Medroxyprogesterone Acetate; Neoplasms; Patient Acceptance of Health Care	1993
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Seminars in oncology, 1998, Volume: 25, Issue:2 Suppl 6 Topics: Anorexia; Appetite Stimulants; Cachexia; Cytokines; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners; Tumor Necrosis Factor-alpha; Wasting Syndrome	1998
[Antiangiogenic therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Angiostatins; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Collagen; Endostatins; Endothelial Growth Factors; Humans; Lymphokines; Medroxyprogesterone Acetate; Mice; Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Plasminogen; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Critical reviews in oncogenesis, 1998, Volume: 9, Issue:2 Topics: Anorexia; Antineoplastic Agents; Appetite Stimulants; Cachexia; Clinical Trials as Topic; Cytokines; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Proteins; Neoplasms; Progesterone Congeners; Serotonin	1998
Medroxyprogesterone acetate and cancer cachexia: interleukin-6 involvement. Breast cancer (Tokyo, Japan), 2000, Volume: 7, Issue:2 Topics: Cachexia; Female; Humans; Interleukin-6; Medroxyprogesterone Acetate; Neoplasms	2000
[Hormonal contraception using depot preparations]. Therapeutische Umschau. Revue therapeutique, 1986, Volume: 43, Issue:5 Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk	1986
Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting. Bulletin of the World Health Organization, 1986, Volume: 64, Issue:3 Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Risk	1986

Trials

10 trial(s) available for medroxyprogesterone acetate and Benign Neoplasms

Article	Year
Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age. American journal of epidemiology, 2021, 02-01, Volume: 190, Issue:3 Topics: Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Postmenopause; Proportional Hazards Models; Pulmonary Embolism; Stroke	2021
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition (Burbank, Los Angeles County, Calif.), 2008, Volume: 24, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antioxidants; Appetite Stimulants; Ascorbic Acid; Basal Metabolism; Cachexia; Carnitine; Dietary Supplements; Exercise; Fatigue; Female; Humans; Interleukin-6; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Muscle Proteins; Neoplasms; Nutritional Support; Oxidative Stress; Treatment Outcome; Tumor Necrosis Factor-alpha; Vitamin A; Vitamin E	2008
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA, 2008, Mar-05, Volume: 299, Issue:9 Topics: Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Risk Assessment	2008
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia. British journal of cancer, 1993, Volume: 67, Issue:5 Topics: Appetite; Cachexia; Double-Blind Method; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Prealbumin; Retinol-Binding Proteins	1993
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:4 Topics: Analysis of Variance; Appetite; Body Weight; Carcinoma, Non-Small-Cell Lung; Digestive System Neoplasms; Double-Blind Method; Female; Humans; Lung Neoplasms; Male; Medroxyprogesterone Acetate; Neoplasm Staging; Neoplasms; Progesterone Congeners; Quality of Life; Treatment Outcome	1996
Effect of medroxyprogesterone acetate on the quality of life of the oncologic patient: a multicentric cooperative study. Anti-cancer drugs, 1997, Volume: 8, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Female; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Quality of Life; Surveys and Questionnaires	1997
Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial. Cancer, 1998, Feb-01, Volume: 82, Issue:3 Topics: Aged; Appetite; Body Composition; Cachexia; Double-Blind Method; Eating; Energy Metabolism; Female; Humans; Male; Medroxyprogesterone Acetate; Neoplasms; Progesterone Congeners; Weight Loss	1998
Effects of high dose medroxyprogesterone acetate on endogenous granulocyte macrophage-colony stimulating factor secretion and bone marrow cellularity in patients under cytotoxic chemotherapy. Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:5 Topics: Adult; Aged; Antigens, CD34; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cell Division; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Neutropenia	1998
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA, 2002, Jul-03, Volume: 288, Issue:1 Topics: Aged; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Cause of Death; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Neoplasms; Postmenopause; Pulmonary Embolism; Risk Factors; Survival Analysis; Thromboembolism; Treatment Outcome; Venous Thrombosis	2002
Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Leukopenia; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Random Allocation; Rectal Neoplasms; Thrombocytopenia; Time Factors	1986

Other Studies

51 other study(ies) available for medroxyprogesterone acetate and Benign Neoplasms

Article	Year
Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium. Biochemical and biophysical research communications, 2022, 11-05, Volume: 628 Topics: Cancer-Associated Fibroblasts; CDC2 Protein Kinase; Drug Resistance, Neoplasm; Endometrial Neoplasms; Endometrium; Female; Humans; Luciferases; Medroxyprogesterone Acetate; Mifepristone; Neoplasms; Receptors, Progesterone; RNA, Messenger; Up-Regulation	2022
Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative. American journal of epidemiology, 2017, Sep-15, Volume: 186, Issue:6 Topics: Aged; Cardiovascular Diseases; Cause of Death; Chronic Disease; Comparative Effectiveness Research; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasms; Postmenopause; Risk Factors; State Medicine; Time Factors; Women's Health	2017
Treatment of cancer cachexia in mice by combination of dsRNA-dependent protein kinase inhibitor and medroxyprogesterone acetate. Oncology reports, 2012, Volume: 27, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Body Weight; Cachexia; Cytokines; Disease Models, Animal; eIF-2 Kinase; Humans; Male; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neoplasms; Protein Kinase Inhibitors; Tumor Burden	2012
Medroxyprogesterone acetate for refractory emesis in cisplatin-treated patients. Journal of palliative medicine, 2012, Volume: 15, Issue:10 Topics: Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Female; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Treatment Outcome; Vomiting	2012
Depo Provera: still controversial. International health news, 1988, Volume: 9, Issue:2 Topics: Americas; Animals, Laboratory; Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Developing Countries; Disease; Economics; Endocrine System; Family Planning Services; Government Agencies; Hormones; Medroxyprogesterone Acetate; Neoplasms; North America; Organizations; Physiology; Politics; Reproductive Control Agents; Research; Technology; United States	1988
Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer. Entre nous (Copenhagen, Denmark), 1996, Issue:32 Topics: Africa; Africa South of the Sahara; Africa, Eastern; Americas; Asia; Asia, Southeastern; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Developing Countries; Disease; Family Planning Services; Health; Injections; Kenya; Latin America; Medroxyprogesterone Acetate; Mexico; Neoplasms; New Zealand; North America; Pacific Islands; Public Health; Safety; Thailand	1996
Injectable medroxyprogesterone. Drug therapy, 1975, Volume: 5 Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Family Planning Services; Injections; Medroxyprogesterone Acetate; Neoplasms	1975
[Cytologic observations of cervicovaginal smears during hormonal contraception]. Revue de cytologie clinique, 1972, Volume: 5, Issue:3 Topics: Age Factors; Belgium; Biology; Birth Rate; Cells; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developed Countries; Disease; Europe; Family Planning Services; Fertility; Genitalia; Genitalia, Female; Lynestrenol; Medroxyprogesterone Acetate; Mestranol; Neoplasms; Parity; Physiology; Population; Population Characteristics; Population Dynamics; Prospective Studies; Research; Urogenital System; Uterine Cervical Neoplasms; Uterus; Vagina; Vaginitis	1972
DMPA for contraception discussed by international forum of experts. Network - International Fertility Research Program, 1979 Topics: Congenital Abnormalities; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Infertility; Injections; Medroxyprogesterone Acetate; Neoplasms	1979
Injectable contraceptives: safe and effective. IPPF medical bulletin, 1982, Volume: 16, Issue:1 Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Politics	1982
[Spermatogenesis protection: myth or reality?]. Contraception, fertilite, sexualite, 1993, Volume: 21, Issue:10 Topics: Androgens; Animals, Laboratory; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Developed Countries; Disease; Endocrine System; Environment; Europe; Family Planning Services; France; Genitalia; Genitalia, Male; Hormones; Infertility; Medroxyprogesterone Acetate; Neoplasms; Pharmaceutical Preparations; Physiology; Reproduction; Research; Spermatogenesis-Blocking Agents; Testis; Testosterone; Therapeutics; Urogenital System	1993
Contraception and cancer prevention. Advances in contraceptive delivery systems : CDS, 1994, Volume: 10, Issue:3-4 Topics: Americas; Biology; Breast Neoplasms; California; Case-Control Studies; Cell Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endocrine System; Endometrial Neoplasms; Estrogens; Family Planning Services; Hormones; Lipids; Medroxyprogesterone Acetate; Neoplasms; North America; Ovarian Neoplasms; Physiology; Pilot Projects; Pituitary Hormone-Releasing Hormones; United States	1994
Long-term use of hormonal contraceptive DMPA not linked to breast cancer. Progress in human reproduction research, 1995, Issue:33 Topics: Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Medroxyprogesterone Acetate; Neoplasms; Risk Factors	1995
20 years, 20 articles: studies to know. Contraceptive technology update, 2000, Volume: 21, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Americas; Breast Feeding; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Developed Countries; Disease; Family Planning Services; Health; HIV Infections; Infant Nutritional Physiological Phenomena; Intrauterine Devices; Lactation; Medroxyprogesterone Acetate; Neoplasms; North America; Nutritional Physiological Phenomena; Research; Sterilization, Reproductive; Sterilization, Tubal; United States; Virus Diseases	2000
Endometrial carcinoma survey in Thailand. IPPF medical bulletin, 1979, Volume: 13, Issue:6 Topics: Asia; Asia, Southeastern; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Data Collection; Developing Countries; Disease; Endometrial Neoplasms; Family Planning Services; Incidence; Injections; Medroxyprogesterone Acetate; Neoplasms; Research; Research Design; Sampling Studies; Thailand	1979
Injectable contraception. IPPF medical bulletin, 1980, Volume: 14, Issue:6 Topics: Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Infertility; Injections; International Agencies; Lactation; Medroxyprogesterone Acetate; Neoplasms; Organizations; Pregnancy; Uterine Cervical Neoplasms; Voluntary Health Agencies; Women	1980
Hormone interference in metastatic breast cancer patients treated with medroxyprogesterone acetate at massive doses: preliminary results. IRCS journal of medical science, 1978, Volume: 6, Issue:4 Topics: Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Family Planning Services; Follicle Stimulating Hormone; Hormones; Luteinizing Hormone; Medroxyprogesterone Acetate; Neoplasms; Physiology; Prolactin	1978
A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. Journal SOGC : journal of the Society of Obstetricians and Gynaecologists of Canada, 1993, Volume: 15, Issue:8 Topics: Americas; Biology; Breast Neoplasms; Canada; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Metabolism; Neoplasms; North America; Patient Acceptance of Health Care; Physiology; Research	1993
Controversy over Depo-Provera. Washington drug & device letter, 1977, Jan-03, Volume: 9, Issue:1 Topics: Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Government Agencies; Injections; Medroxyprogesterone Acetate; Neoplasms; North America; Organizations; Physicians; United States; Uterine Cervical Neoplasms	1977
Depo-Provera: just another contraceptive? Fertility and contraception, 1978, Volume: 2, Issue:2 Topics: Amenorrhea; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; England; Europe; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Legislation as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Neoplasms; North America; Signs and Symptoms; United Kingdom; United States	1978
Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell]. Contraceptive technology update, 1981, Volume: 2, Issue:3 Topics: Americas; Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Delivery of Health Care; Developed Countries; Disease; Endocrine System; Estrogens; Evaluation Studies as Topic; Family Planning Services; Health Planning; Health Services Accessibility; Hormones; Injections; Medroxyprogesterone Acetate; Neoplasms; North America; Organization and Administration; Physicians; Physiology; Politics; United States	1981
Statement on injectable contraception. IPPF medical bulletin, 1982, Volume: 16, Issue:6 Topics: Animals, Laboratory; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Injections; International Agencies; Lactation; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Organizations; Research; Steroids; Uterine Cervical Neoplasms	1982
Not FDA-approved, but experts recommend Depo-Provera. Contraceptive technology update, 1992, Volume: 13, Issue:1 Topics: Americas; Breast Neoplasms; Consumer Product Safety; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Delivery of Health Care; Developed Countries; Disease; Drug Prescriptions; Evaluation Studies as Topic; Family Planning Services; Health Planning; Legislation as Topic; Medroxyprogesterone Acetate; Neoplasms; North America; Organization and Administration; Risk Assessment; United States	1992
What is breast cancer risk with Depo-Provera? Contraceptive technology update, 1992, Volume: 13, Issue:1 Topics: Age Factors; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Demography; Disease; Evaluation Studies as Topic; Family Planning Services; International Agencies; Medroxyprogesterone Acetate; Neoplasms; Organizations; Population; Population Characteristics; Population Dynamics; Research; Research Design; Risk Assessment; Time; Time Factors; United Nations; World Health Organization	1992
FDA gives final approval to Depo amid concerns over safety, cost and coercion. Washington memo, 1992, Nov-12, Issue:17 Topics: Americas; Breast Neoplasms; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Developing Countries; Disease; Economics; Endometrial Neoplasms; Family Planning Services; Government Agencies; International Agencies; Medroxyprogesterone Acetate; Neoplasms; North America; Organizations; Ovarian Neoplasms; Ovulation; Poverty; Social Class; Socioeconomic Factors; United Nations; United States; United States Public Health Service; Uterine Cervical Neoplasms; World Health Organization	1992
FDA advisory panel recommends approval for Depo-Provera. Contraceptive technology update, 1992, Volume: 13, Issue:10 Topics: Americas; Biology; Birth Weight; Body Weight; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Infant, Low Birth Weight; Injections; Legislation as Topic; Medroxyprogesterone Acetate; Neoplasms; North America; Physiology; United States	1992
Contraception and the big "C". Malaysian journal of reproductive health : a publication of the Reproductive Research Centre of the National Population and Family Development Board, Malaysia, 1992, Volume: 10, Issue:1 Topics: Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Demography; Disease; Endocrine System; Endometrial Neoplasms; Estrogens; Family Planning Services; Hormones; Intrauterine Devices; Lactation; Medroxyprogesterone Acetate; Neoplasms; Ovarian Neoplasms; Ovulation; Physiology; Population; Population Dynamics; Time; Time Factors; Uterine Cervical Neoplasms	1992
Injectable contraception: the USA perspective. IPPF medical bulletin, 1992, Volume: 26, Issue:6 Topics: Americas; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Health Services Accessibility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service	1992
MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE. American journal of obstetrics and gynecology, 1965, May-01, Volume: 92 Topics: Adenocarcinoma; Disease Management; Female; Geriatrics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Palliative Care; Uterine Neoplasms	1965
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:6 Topics: Aged; Body Mass Index; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Neoplasms; Obesity; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Women's Health	2006
Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer, 2006, Oct-01, Volume: 107, Issue:7 Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Menorrhagia; Neoplasms; Retrospective Studies; Thrombocytopenia; Triptorelin Pamoate	2006
ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:4 Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Uterine Neoplasms	1984
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology. Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:2 Topics: Biological Availability; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Time Factors	1982
Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patients. Cancer chemotherapy and pharmacology, 1982, Volume: 9, Issue:2 Topics: Administration, Oral; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms	1982
Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients. Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:1 Topics: Administration, Oral; Antineoplastic Agents; Biological Availability; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms	1983
The anabolic effect of high dose medroxyprogesterone acetate in oncology. Pharmacological research communications, 1983, Volume: 15, Issue:6 Topics: Anabolic Agents; Anorexia; Hemodynamics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Nitrogen; Pain; Psychomotor Performance	1983
Mortality among young black women using contraceptives. JAMA, 1984, Feb-24, Volume: 251, Issue:8 Topics: Adolescent; Adult; Black or African American; Contraception; Contraceptives, Oral; Family Planning Services; Female; Georgia; Humans; Intrauterine Devices; Medroxyprogesterone; Medroxyprogesterone Acetate; Mortality; Neoplasms; Parity; Risk; Vaginal Creams, Foams, and Jellies	1984
[The occurrence of mammary tumors in bitches following treatment with Delvosteron injection or Perlutex injection for the prevention of estrus, compared to 2 control groups]. Tijdschrift voor diergeneeskunde, 1984, Feb-15, Volume: 109, Issue:4 Topics: Animals; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners	1984
Quality of life after cytotoxic chemotherapy: discussion paper. Journal of the Royal Society of Medicine, 1984, Volume: 77, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Quality of Life; Self-Assessment; Surveys and Questionnaires	1984
[Real and false risks of injectable hormonal contraception]. Gynakologische Rundschau, 1984, Volume: 24 Suppl 1 Topics: Abnormalities, Drug-Induced; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Pregnancy; Risk	1984
The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patients. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:5 Topics: Antineoplastic Agents; Body Water; Electrolytes; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Water-Electrolyte Balance	1984
Oestrus control and the incidence of mammary nodules in bitches, a clinical study with two progestogens. The veterinary quarterly, 1981, Volume: 3, Issue:1 Topics: Animals; Contraception; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners	1981
Depo-Provera: a critical analysis. Women & health, 1980,Summer, Volume: 5, Issue:2 Topics: Abnormalities, Drug-Induced; Animals; Breast Feeding; Contraceptive Agents, Female; Dogs; Female; Haplorhini; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; United States; United States Food and Drug Administration; Uterine Neoplasms	1980
Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Biochemical Society transactions, 1997, Volume: 25, Issue:2 Topics: Anorexia; Antigens, CD; Cachexia; Cells, Cultured; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukins; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone Acetate; Neoplasms; Receptors, Interleukin-2; Serotonin; Tumor Necrosis Factor-alpha; Vomiting	1997
Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:4 Topics: Aged; Anorexia; Antineoplastic Agents, Hormonal; Cachexia; Cell Division; Cells, Cultured; Cytokines; Female; Humans; Interleukin-1; Interleukin-2; Interleukin-6; Leukocytes, Mononuclear; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Receptors, Interleukin-2; Serotonin; Tumor Necrosis Factor-alpha; Vomiting	1997
Cachexia and anorexia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:6 Topics: Anorexia; Cachexia; Cytokines; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners	2000
U.S. approves injectable drug as birth control. The New York times on the Web, 1992, Oct-30 Topics: Coercion; Contraception; Federal Government; Female; Government; Government Regulation; Humans; International Cooperation; Internationality; Medroxyprogesterone Acetate; Neoplasms; Pharmaceutical Preparations; Risk; Risk Assessment; Social Control, Formal; Socioeconomic Factors; United States; United States Food and Drug Administration; Vulnerable Populations; Women; Women's Health	1992
Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer. Human reproduction (Oxford, England), 2002, Volume: 17, Issue:7 Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Gonads; Humans; Hypothalamo-Hypophyseal System; Immunohistochemistry; Male; Medroxyprogesterone Acetate; Neoplasms; Oligospermia; Radiation Injuries; Receptors, Androgen; Spermatogenesis; Testis	2002
Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing factor. Cancer, 1990, Nov-01, Volume: 66, Issue:9 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; beta-Endorphin; Corticotropin-Releasing Hormone; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Pituitary Gland, Anterior; Pituitary-Adrenal System	1990
The role of pharmacokinetics in the clinical treatment of metastases. Advances in experimental medicine and biology, 1988, Volume: 233 Topics: Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms; Tamoxifen	1988
Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancer. Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:3 Topics: Antineoplastic Agents; Biological Availability; Humans; Injections, Intraperitoneal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms	1985